Denosumab and Bone Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Global Phase 3, Randomised, Placebo-Controlled Trial

BACKGROUND: Bone metastases are a major cause of morbidity and mortality in men with prostate cancer. Preclinical studies suggest that osteoclast inhibition may prevent bone metastases. This phase 3 study evaluated denosumab, a fully human anti-RANKL monoclonal antibody, to prevent bone metastasis o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Matthew R, Saad, Fred, Coleman, Robert, Shore, Neal, Fizazi, Karim, Tombal, Bertrand, Miller, Kurt, Sieber, Paul, Karsh, Lawrence, Damião, Ronaldo, Tammela, Teuvo L, Egerdie, Blair, Van Poppel, Hendrik, Chin, Joseph, Morote, Juan, Gómez-Veiga, Francisco, Borkowski, Tomasz, Ye, Zhishen, Kupic, Amy, Dansey, Roger, Goessl, Carsten
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671878/
https://ncbi.nlm.nih.gov/pubmed/22093187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(11)61226-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados